Science Committee

The Science Committee evaluates new scientific evidence about COPD care, and prepares updates to scientific reports on COPD diagnosis, management, and prevention.

All Board of Director members also serve on the Science Committee. 

 
Science Committee
Disclosures

Shawn Aaron, MD

The Ottawa Hospital Research Insitute
University of Ottawa

Ottawa, Canada

Antonio Anzueto, MD

South Texas Veterans Health Care System
University of Texas, Health

San Antonio, Texas, USA

Jean Bourbeau, MD

McGill University Health Centre Montreal
McGill University

Montreal, Canada

MeiLan K. Han, MD MS

University of Michigan

Ann Arbor, Michigan, USA

Fernando Martinez, MD MS

University of Massachusetts Chan Medical School

Worcester, MA

Alberto Papi, MD

University of Ferrara

Ferrara, Italy

Ian Pavord, MA DM

Respiratory Medicine Unit and Oxford
Respiratory NIHR Biomedical Research
Centre, Nuffield Department of Medicine
University of Oxford

Oxford, UK

Nicolas Roche, MD

Pneumologie, Hôpital Chochin,
AP-HP.Centre - Université de Paris
UMR 1016
Institut Chochin

Paris, France

Don Sin, MD, FRCPC, MPH

University of British Columbia

Vancouver, Canada

Dave Singh, MD

University of Manchester

Manchester, UK

Thierry Troosters

Research Group for Rehabilitation in Internal Disorders
Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE)

Leuven, Belgiu

Jadwiga A. Wedzicha, MD

National Heart & Lung Institute
Imperial College London

London, UK

GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

View Board and Science Committee Disclosures